The Impact of Cognitive Function on Health-Related Quality of Life in Persons with Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine (S19.003)
Our objective was to investigate the effects of cognitive function on health-related quality of life (HRQoL) in individuals with post-COVID-19 condition (PCC). Additionally, we aimed to determine whether vortioxetine modulates the relationship between cognitive function and HRQoL.
Authors
- Angela T.H. Kwan (ORCID: https://orcid.org/0000-0003-4013-1112)
- Joshua D. Rosenblat (ORCID: https://orcid.org/0000-0002-4773-2191)
- Kayla M. Teopiz (ORCID: https://orcid.org/0000-0001-8429-6563)
- Moiz Lakhani (ORCID: https://orcid.org/0009-0009-4603-826X)
- Ziji Guo
- Arshpreet Singh Manku
- Greg Rhee
- Roger S. McIntyre
Institutions
- University of British Columbia (CA)
- University of Ottawa (CA)
- University of Pittsburgh (US)
- University of Toronto (CA)
- Brain and Cognition Discovery Foundation (CA)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000209083
- Primary Topic
- Intensive Care Unit Cognitive Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00